Skip to main content
Clinical Trials/NCT06698302
NCT06698302
Recruiting
N/A

Validation of COMPAT-SF Spanish Translation

Methodist Health System1 site in 1 country100 target enrollmentSeptember 13, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Chronic Pancreatitis
Sponsor
Methodist Health System
Enrollment
100
Locations
1
Primary Endpoint
Face validity:
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.

Detailed Description

Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.

Registry
clinicaltrials.gov
Start Date
September 13, 2024
End Date
September 13, 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years or older in age
  • Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
  • Able to read and understand the study information in Spanish
  • Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study
  • Subject is willing and able to comply with the scheduled questionnaires

Exclusion Criteria

  • Subjects who do not meet the criteria in section 4.1

Outcomes

Primary Outcomes

Face validity:

Time Frame: through study completion, up to 18 months

Patient-reported feedback through a questionnaire concerning the feasibility of the translated COMPAT-SF questionnaire

Study Sites (1)

Loading locations...

Similar Trials